Peregrine Capital Management LLC Acquires 63,464 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Peregrine Capital Management LLC grew its position in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 56.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 176,539 shares of the company's stock after buying an additional 63,464 shares during the period. Peregrine Capital Management LLC owned approximately 0.28% of Guardian Pharmacy Services worth $3,753,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Envestnet Asset Management Inc. increased its holdings in Guardian Pharmacy Services by 4.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company's stock worth $243,000 after buying an additional 564 shares in the last quarter. LPL Financial LLC boosted its holdings in shares of Guardian Pharmacy Services by 4.8% during the 4th quarter. LPL Financial LLC now owns 17,679 shares of the company's stock valued at $358,000 after acquiring an additional 807 shares during the last quarter. GAMMA Investing LLC bought a new stake in shares of Guardian Pharmacy Services in the first quarter worth approximately $170,000. Lazard Asset Management LLC grew its stake in shares of Guardian Pharmacy Services by 0.5% in the fourth quarter. Lazard Asset Management LLC now owns 190,797 shares of the company's stock worth $3,865,000 after acquiring an additional 860 shares during the period. Finally, BNP Paribas Financial Markets purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $37,000.

Guardian Pharmacy Services Stock Performance

Shares of GRDN traded up $0.26 on Thursday, reaching $20.85. The company's stock had a trading volume of 78,441 shares, compared to its average volume of 185,545. The stock's 50 day simple moving average is $22.44 and its two-hundred day simple moving average is $21.52. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The firm had revenue of $329.31 million for the quarter, compared to analysts' expectations of $321.21 million. On average, equities research analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Raymond James Financial set a $28.00 target price on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a report on Wednesday, May 14th. Truist Financial restated a "buy" rating and issued a $28.00 price target (up from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th. Finally, Wall Street Zen cut Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th.

Insiders Place Their Bets

In other news, Director Thomas J. Salentine, Jr. sold 651,454 shares of Guardian Pharmacy Services stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total transaction of $13,133,312.64. Following the transaction, the director directly owned 1,939,817 shares of the company's stock, valued at $39,106,710.72. The trade was a 25.14% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John Ackerman sold 201,303 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $4,058,268.48. Following the transaction, the director owned 149,794 shares of the company's stock, valued at approximately $3,019,847.04. This trade represents a 57.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 11,344,912 shares of company stock valued at $228,713,426. 63.71% of the stock is currently owned by corporate insiders.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.